Fabtech Technologies LimitedQuarter ended September 30, 2026 Results & Financial Update
Fabtech Technologies Limited: Quarter ended September 30, 2026 consolidated results and company financials – revenue ₹92.09 Cr, PAT ₹15.02 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceReported figures and period changes.Changes compare like-for-like reported periods where available.
Find an answer
Ask this result
Chart · Market context
Fabtech Technologies price & chart
Market price₹130.30
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Fabtech Technologies Quarter ended September 30, 2026 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Fabtech Technologies reported consolidated revenue from operations of INR 92.09 crore for the quarter ended September 30, 2026, registering sequential growth compared to the previous quarter alongside a contraction relative to the same period in the prior fiscal year.
Total consolidated income for the second quarter reached INR 97.54 crore, bolstered by other income components including investment returns and non-operating inflows during the period.
Profit before tax (PBT) for the quarter stood at INR 21.72 crore, which was substantially higher than the preceding quarter's figure, aided significantly by the recognition of an exceptional item relating to the divestment of equity investments.
Net profit after tax (PAT) for the quarter closed at INR 15.02 crore, delivering a higher bottom-line performance than the June 2026 quarter but remaining below the robust levels recorded in the corresponding quarter of the previous year.
The bottom line received a notable one-off boost from the completion of the second tranche sale of the company's equity investment in TSA Process Equipments Private Limited, generating a substantial exceptional gain during the quarter.
Total expenses for the quarter remained elevated at INR 84.26 crore, reflecting continued outlays in material purchases, inventory adjustments, employee remuneration, and operational expenditures required to support ongoing turnkey execution.
Basic and diluted earnings per share (EPS) for the quarter settled at INR 3.38 per share, reflecting the improved profitability trajectory over the preceding quarter's EPS of INR 0.95.
01 · Business model
What does Fabtech Technologies do?
Fabtech Technologies Limited operates in the specialized engineering sector, providing comprehensive turnkey project solutions, pharmaceutical machinery, equipment, and in-house designing and engineering services tailored for pharmaceutical and allied industries.
The company's revenue engines are driven by executing complex, multi-disciplinary turnkey pharma projects across diverse domestic and international geographies, supported by a network of subsidiaries and associates.
Geographically, Fabtech has established an extensive operational footprint spanning key international markets including the United Arab Emirates, Saudi Arabia, Morocco, Kenya, and other regions alongside its core domestic operations in India.
The economic model relies on capturing high-value turnkey contracting orders, managing complex component procurement and custom manufacturing, and scaling project execution capacity across high-growth pharmaceutical hubs in the Middle East and Africa.
02 · Historical context
What shaped the business before this quarter
Previously on February 06, 2024, the company entered into a Share Purchase and Share Subscription Agreement with Thermax Limited to sell its 33.33% equity investment in associate TSA Process Equipments Private Limited in two tranches.
The first tranche comprising 17% of the TSA investment was successfully executed and completed on April 18, 2024.
The company completed its initial public offering of 1,20,60,000 equity shares at INR 10 face value, issuing 1,20,58,555 shares on October 03, 2025, with shares subsequently listing on NSE and BSE on October 07, 2025.
03 · Financial snapshot
Current quarter vs the two useful baselines
| Metric | Quarter ended September 30, 2026 | Year-ago | Previous quarter |
|---|---|---|---|
| Revenue from operations | ₹92.09 Cr | ₹121.48 Cr | ₹74.98 Cr |
| Total income | ₹97.54 Cr | ₹124.28 Cr | ₹78.15 Cr |
| Profit before tax | ₹21.72 Cr | ₹31.26 Cr | ₹0.00 Cr |
| Profit after tax | ₹15.02 Cr | ₹28.11 Cr | ₹4.21 Cr |
| EPS | ₹3.38 | ₹8.68 | ₹0.95 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 16.3% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 23.6% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹5.45 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Segment performance highlights substantial revenue contributions from overseas markets, led by Saudi Arabia with INR 29.09 crore and Rest of the World shipments contributing INR 37.08 crore during the quarter.
Operations within India contributed INR 15.09 crore to gross segment revenues for the quarter ended September 30, 2026.
What drove margins
Purchase of stock-in-trade stood at INR 50.40 crore, offset by negative inventory changes of INR 5.49 crore, reflecting dynamic inventory utilization across active project sites.
Employee benefit expenses reached INR 11.25 crore, while other expenses scaled to INR 26.81 crore to support complex engineering services and administrative overheads.
05 · Demand, customers & order book
Where demand is coming from
Gross trade receivables expanded to INR 234.84 crore as of September 30, 2026, reflecting extended billing cycles and sizeable order executions across international geographies.
06 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
Saudi Arabia emerged as the largest revenue contributor at INR 29.09 crore, followed by Rest of the World at INR 37.08 crore, UAE at INR 9.05 crore, India at INR 15.09 crore, Morocco at INR 5.12 crore, and Kenya at INR 4.55 crore.
Geography and market mix
Subsidiary Fabtech Technologies LLC advanced plans for incorporating step-down subsidiaries in the Kingdom of Saudi Arabia for specialized contracting and in Egypt for turnkey pharma projects.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
The company continues to deploy specialized in-house designing, engineering, and manufacturing capabilities to support pharmaceutical equipment supply and turnkey installations.
Projects, capex and execution
Additional capital investments of up to INR 24.00 crore in Fabtech Technologies LLC and INR 2.49 crore in FT Institutions Private Limited were approved and executed via overseas and domestic direct investments.
08 · Strategy & new businesses
How the company is trying to change its growth mix
Strategic steps were undertaken to establish operational bases in Saudi Arabia and Egypt through subsidiary-led incorporation agreements to capture regional pharmaceutical engineering demand.
09 · Reported developments
What changed operationally
The completion of the second tranche sale of TSA Process Equipments Private Limited yielded an exceptional profit of INR 8.35 crore during the quarter.
10 · Items worth noticing
The line items that can distort a quick read
The company recorded an exceptional profit of INR 835.25 lakhs (INR 8.35 crore) from the completion of the second and final tranche sale of its equity investment in TSA Process Equipments Private Limited.
11 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Net cash used in operating activities for the half year ended September 30, 2026, stood at INR 41.14 crore, impacted by changes in operating assets and trade receivables.
Capital allocation & funding
Non-current borrowings stood at INR 0.39 crore alongside current borrowings of INR 30.90 crore, complemented by lease liabilities across non-current and current books.
12 · Beyond the numbers
What changed beyond the numbers
Reported update
Senior Management Personnel Appointment
The Board of Directors approved the appointment of Mr. Alan Dias as Vice President - HR and Senior Management Personnel effective October 28, 2026.
13 · Previous-quarter changes
What changed since the previous quarter
Consolidated PAT recovered from INR 4.21 crore in the quarter ended June 30, 2026, to INR 15.02 crore in the September 2026 quarter, supported by exceptional items and higher operating revenues.
14 · Key Q&A
The quarter, answered directly
What does Fabtech Technologies do?
Fabtech Technologies Limited operates in the specialized engineering sector, providing comprehensive turnkey project solutions, pharmaceutical machinery, equipment, and in-house designing and engineering services tailored for pharmaceutical and allied industries.
What is the clearest takeaway from Quarter ended September 30, 2026?
Fabtech Technologies reported consolidated revenue from operations of INR 92.09 crore for the quarter ended September 30, 2026, registering sequential growth compared to the previous quarter alongside a contraction relative to the same period in the prior fiscal year.
What drove revenue or demand?
Segment performance highlights substantial revenue contributions from overseas markets, led by Saudi Arabia with INR 29.09 crore and Rest of the World shipments contributing INR 37.08 crore during the quarter.
What mattered most for margins or profitability?
Purchase of stock-in-trade stood at INR 50.40 crore, offset by negative inventory changes of INR 5.49 crore, reflecting dynamic inventory utilization across active project sites.
What changed operationally beyond the headline numbers?
The company continues to deploy specialized in-house designing, engineering, and manufacturing capabilities to support pharmaceutical equipment supply and turnkey installations.
What should the next disclosure help confirm?
Monitor the regulatory approvals and operational commencement of the proposed step-down subsidiaries in Saudi Arabia and Egypt.
15 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
16 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Subsidiary Incorporations: Monitor the regulatory approvals and operational commencement of the proposed step-down subsidiaries in Saudi Arabia and Egypt.
- 02
IPO Proceeds Utilization: Track the deployment of the remaining unutilized IPO proceeds, particularly towards working capital requirements and inorganic growth initiatives.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.